Predictive Value of Admission N-Terminal Pro-B-Type Natriuretic Peptide and Renal Function in Older People Hospitalized for Dyspnoea

被引:2
|
作者
Fabbian, Fabio [1 ]
De Giorgi, Alfredo [1 ]
Pala, Marco [1 ]
Volpato, Stefano [2 ]
Portaluppi, Francesco [1 ]
Zuliani, Giovanni [2 ]
Manfredini, Roberto [1 ]
机构
[1] Azienda Osped Univ S Anna, Dept Med Sci, Sect Clin Med, Ferrara, Italy
[2] Azienda Osped Univ S Anna, Dept Med Sci, Sect Internal Med Gerontol & Clin Nutr, Ferrara, Italy
关键词
GLOMERULAR-FILTRATION-RATE; CHRONIC HEART-FAILURE; ELDERLY-PATIENTS; CARDIAC DYSFUNCTION; MORTALITY; DIAGNOSIS; RISK; BNP; DISEASE; DEATH;
D O I
10.1155/2013/687467
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. We investigated the relationship between NT-pro-BNP, glomerular filtration rate (GFR), and all-cause mortality rates in a cohort of older people discharged froman internal medicine unit after admission for dyspnoea. Patients and Methods. NT-pro-BNP was evaluated in serum samples of 134 patients aged 80 +/- 6 years who presented to a single academic centre with worsening dyspnoea. History data and anthropometric, clinical, and biochemical parameters including GFR were collected at the time of admission. 119 out of 134 were discharged alive from hospital and were included in the follow-up of 779 +/- 370 days. Results. 35 out of 119 subjects died after a follow-up of 266 +/- 251 days. Cox proportional hazards model showed that GFR and Ln (NT-pro-BNP) were predictors for all-cause mortality with estimated hazard ratios of 0.969 (95% confidence interval: 0.950-0.988; P = 0.001) and 2.360 (95% confidence interval: 1.208-4.610; P = 0.012), respectively. Patients characterized by high NT-pro-BNP levels and GFR = 60 mL/min/1.73m(2) showed a dramatic reduction in survival duration compared with the groups with different combinations of the two variables (P = 0.008). Conclusions. In the elderly, NT-pro-BNP and GFR are predictors of all-cause mortality after admission because of dyspnoea. Since the fact that subjects with high NT-pro-BNP and GFR = 60 mL/min/1.73m(2) exhibited a reduced survival, high admission NT-pro-BNP suggests future negative outcome.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 50 条
  • [21] Prognostic value of N-terminal pro-B-type natriuretic peptide in adults with congenital heart disease
    Baggen, V. J. M.
    Van den Bosch, A. E.
    Eindhoven, J. A.
    Cuypers, J. A. A. E.
    Witsenburg, M.
    De Waart, M.
    Boersma, E.
    Roos-Hesselink, J. W.
    EUROPEAN HEART JOURNAL, 2016, 37 : 574 - 574
  • [22] Prognostic value of N-terminal Pro-B-Type natriuretic peptide in patients with intermediate coronary lesions
    Song, Chenxi
    Yuan, Sheng
    Cui, Kongyong
    Cai, Zhongxing
    Zhang, Rui
    He, Jining
    Qiao, Zheng
    Bian, Xiaohui
    Wu, Shaoyu
    Wang, Haoyu
    Fu, Rui
    Wang, Chunyue
    Liu, Qianqian
    Yin, Dong
    Jia, Lei
    Dou, Kefei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction
    Drewniak, Wojciech
    Snopek, Grazyna
    Zarukiewicz, Magdalena
    Borys, Marcin
    Dabrowski, Marek
    KARDIOLOGIA POLSKA, 2008, 66 (07) : 750 - 755
  • [24] The Predictive Value and Evolution of N-Terminal Pro-B-Type Natriuretic Peptide Levels Following Transcutaneous Aortic Valve Implantation
    Spargias, Konstantinos
    Polymeros, Spyros
    Dimopoulos, Antonis
    Manginas, Athanassios
    Pavlides, Gregory
    Balanika, Marina
    Smirli, Anna
    Stavridis, George
    Dangas, George
    Cokkinos, Dennis V.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (05) : 462 - 469
  • [25] Direct comparison of B-type natriuretic peptide and n-terminal pro-B-type natriuretic peptide in the management of patients with acute dyspnea and impaired renal function
    Murray, K.
    Wildi, K.
    Moehring, B.
    Meller, B.
    Breidthardt, T.
    Reichlin, T.
    Stallone, F.
    Eckstein, J.
    Osswald, S.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 776 - 776
  • [26] Relation of N-Terminal Pro-B-Type Natriuretic Peptide With Diastolic Function in Hypertensive Heart Disease
    Uraizee, Imran
    Cheng, Susan
    Hung, Chung-Lieh
    Verma, Anil
    Thomas, James D.
    Zile, Michael R.
    Aurigemma, Gerard P.
    Solomon, Scott D.
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (10) : 1234 - 1241
  • [27] N-terminal Pro-B-type Natriuretic Peptide and Ventricular Dysfunction in Children and Adolescents
    Kocharian, Armen
    Shabanian, Reza
    Rahimzadeh, Mitra
    Kiani, Abdolrazagh
    Hosseini, Ahmad
    Zanjani, Keyhan Sayadpour
    Heidari-Bateni, Giv
    Hosseini-Navid, Nasrollah
    CARDIOLOGY IN THE YOUNG, 2009, 19 (06) : 580 - 588
  • [28] N-terminal pro-B-type natriuretic peptide in the diagnosis of acute heart failure
    Lee, K. K.
    Doudesis, D.
    Anwar, M.
    Astengo, F.
    Japp, A.
    Tsanas, A.
    Shah, A. S., V
    Januzzi, J. L.
    Mills, N. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1210 - 1210
  • [29] N-Terminal Pro-B-Type Natriuretic Peptide Variability in Stable Dialysis Patients
    Fahim, Magid A.
    Hayen, Andrew
    Horvath, Andrea R.
    Dimeski, Goce
    Coburn, Amanda
    Johnson, David W.
    Hawley, Carmel M.
    Campbell, Scott B.
    Craig, Jonathan C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (04): : 620 - 629
  • [30] N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
    Mangge, Harald
    Almer, Gunter
    Zelzer, Sieglinde
    Vasan, Ramachandran
    Kraigher-Krainer, Elisabeth
    Gasser, Robert
    Schnedl, Wolfgang
    Ille, Rottraut
    Wallner, Sandra
    Moeller, Reinhard
    Horejsi, Renate
    Weghuber, Daniel
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) : 1539 - 1545